专题：Blood groups and transfusion

This cluster of papers explores the relationship between blood group variants, such as ABO and Rh, and various diseases including autoimmune hemolytic anemia, fetal anemia, COVID-19 susceptibility, and pancreatic cancer. It also investigates the impact of alloimmunization and RBC antigens on transfusion outcomes and disease risk.
最新文献
Utility of First‐Line Diagnostic Tests and Molecular Methods for Accurate Characterization of Sickle Cell Disorders

article Full Text OpenAlex

Concerns regarding methodological and interpretive aspects in the evaluation of BTHC ‐ PAGGSM red cell storage

article Full Text OpenAlex

Low-dose aspirin for preventing intrauterine growth restriction and pre-eclampsia in sickle cell pregnancy

article Full Text OpenAlex

Low-dose aspirin for preventing intrauterine growth restriction and pre-eclampsia in sickle cell pregnancy in Nigeria (PIPSICKLE): a randomised controlled trial

article Full Text OpenAlex

Acquired Pure Red Cell Aplasia Following BNT162b2 mRNA COVID-19 Vaccination

article Full Text OpenAlex

Epitope Recognized by anti-A,B Antibodies of Blood Group O Individuals as Probed with STD NMR

article Full Text OpenAlex

Ravulizumab for Treatment of Paroxysmal Nocturnal Hemoglobinuria During Pregnancy

article Full Text OpenAlex

A Rising Cluster of Erythropoietin‐Associated Pure Red Cell Aplasia and Subsequent Response to Roxadustat: A Case Series

article Full Text OpenAlex

Successful Treatment of Oxaliplatin‐Induced Immune Thrombocytopenia in a Schizophrenic Patient With Contraindication to Steroids Using Cyclosporine Plus Eltrombopag: A Case Report

article Full Text OpenAlex

Infant Immunity after Maternal Nipocalimab in Severe Hemolytic Disease of the Fetus and Newborn

article Full Text OpenAlex

近5年高被引文献
Sickle Cell Disease

review Full Text OpenAlex 385 FWCI54.9308

Vaccination induces HIV broadly neutralizing antibody precursors in humans

article Full Text OpenAlex 247 FWCI16.7585

2021 Thalassaemia International Federation Guidelines for the Management of Transfusion-dependent Thalassemia

article Full Text OpenAlex 239 FWCI34.1262

The therapeutic age of the neonatal Fc receptor

review Full Text OpenAlex 219 FWCI52.4901

The complement system and human autoimmune diseases

review Full Text OpenAlex 146 FWCI11.6471

Non-invasive Anemia Detection and Prediagnosis

article Full Text OpenAlex 139 FWCI67.527

Treatment of chemotherapy-induced thrombocytopenia in patients with non-hematologic malignancies

article Full Text OpenAlex 131 FWCI20.3672

Understanding Sickle cell disease: Causes, symptoms, and treatment options

review Full Text OpenAlex 126 FWCI36.9553

A Randomized Phase 2 Trial of Felzartamab in Antibody-Mediated Rejection

article Full Text OpenAlex 124 FWCI64.9825

Alternative Complement Pathway Inhibition with Iptacopan in IgA Nephropathy

article Full Text OpenAlex 124 FWCI43.1734